These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8790482)

  • 1. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population screening for haemochromatosis: a unifying analysis of published intervention trials.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):178-84. PubMed ID: 9041481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of haemochromatosis amongst asymptomatic Australians.
    Leggett BA; Halliday JW; Brown NN; Bryant S; Powell LW
    Br J Haematol; 1990 Apr; 74(4):525-30. PubMed ID: 2346731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons.
    Asberg A; Hveem K; Thorstensen K; Ellekjter E; Kannelønning K; Fjøsne U; Halvorsen TB; Smethurst HB; Sagen E; Bjerve KS
    Scand J Gastroenterol; 2001 Oct; 36(10):1108-15. PubMed ID: 11589387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hereditary hemochromatosis.
    Phatak PD; Cappuccio JD
    Blood Rev; 1994 Dec; 8(4):193-8. PubMed ID: 7888827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands.
    Bradley LA; Haddow JE; Palomaki GE
    J Med Screen; 1996; 3(4):171-7. PubMed ID: 9041480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of hereditary hemochromatosis among healthy workers. Diagnostic value of transferrin saturation assay].
    Martínez-Vázquez C; Martínez Cadilla J; Gil M; Sopeña B; Torres J; Cordeiro E; Seijas M; de la Fuente J; Méndez MJ
    An Med Interna; 2000 Dec; 17(12):628-31. PubMed ID: 11213576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary hemochromatosis.
    Crownover BK; Covey CJ
    Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for haemochromatosis: prevalence among Danish blood donors.
    Wiggers P; Dalhøj J; Kiaer H; Ring-Larsen H; Petersen PH; Blaabjerg O; Hørder M
    J Intern Med; 1991 Sep; 230(3):265-70. PubMed ID: 1895049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for haemochromatosis in the diabetic clinic.
    George DK; Evans RM; Crofton RW; Gunn IR
    Ann Clin Biochem; 1995 Nov; 32 ( Pt 6)():521-6. PubMed ID: 8579282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for haemochromatosis: influence of analytical imprecision, diagnostic limit and prevalence on test validity.
    Wiggers P; Dalhøj J; Hyltoft Petersen P; Blaabjerg O; Hørder M
    Scand J Clin Lab Invest; 1991 Apr; 51(2):143-8. PubMed ID: 2042019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemochromatosis.
    Adams PC; Barton JC
    Lancet; 2007 Dec; 370(9602):1855-60. PubMed ID: 18061062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.
    Ellervik C; Mandrup-Poulsen T; Nordestgaard BG; Larsen LE; Appleyard M; Frandsen M; Petersen P; Schlichting P; Saermark T; Tybjaerg-Hansen A; Birgens H
    Lancet; 2001 Oct; 358(9291):1405-9. PubMed ID: 11705485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for genetic haemochromatosis in a rheumatology clinic.
    Olynyk J; Hall P; Ahern M; Kwiatek R; Mackinnon M
    Aust N Z J Med; 1994 Feb; 24(1):22-5. PubMed ID: 8002853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of 5 patients with possible primary hemochromatosis].
    Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction between homozygous and heterozygous subjects with hereditary haemochromatosis using iron status markers and receiver operating characteristic (ROC) analysis.
    Milman N; Albeck MJ
    Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):95-8. PubMed ID: 7632826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.